Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Outset Medical (OM) Operating Income (2019 - 2025)

Outset Medical (OM) has disclosed Operating Income for 7 consecutive years, with $32.1 million as the latest value for Q4 2025.

  • On a quarterly basis, Operating Income rose 246.75% to $32.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$17.0 million, a 85.01% increase, with the full-year FY2025 number at -$17.0 million, up 85.01% from a year prior.
  • Operating Income was $32.1 million for Q4 2025 at Outset Medical, up from -$15.8 million in the prior quarter.
  • In the past five years, Operating Income ranged from a high of $32.1 million in Q4 2025 to a low of -$45.5 million in Q3 2023.
  • A 5-year average of -$29.6 million and a median of -$33.6 million in 2022 define the central range for Operating Income.
  • Peak YoY movement for Operating Income: tumbled 46.84% in 2021, then surged 246.75% in 2025.
  • Outset Medical's Operating Income stood at -$40.8 million in 2021, then increased by 2.39% to -$39.8 million in 2022, then rose by 6.2% to -$37.4 million in 2023, then soared by 41.48% to -$21.9 million in 2024, then soared by 246.75% to $32.1 million in 2025.
  • Per Business Quant, the three most recent readings for OM's Operating Income are $32.1 million (Q4 2025), -$15.8 million (Q3 2025), and -$16.9 million (Q2 2025).